Dr. Abud Bakri
π€ SpeakerAppearances Over Time
Podcast Appearances
From the copper, yeah.
There you go.
That makes sense.
But that doesn't mean that it's real.
It could be copper that's fallen out of the complex of the GHK.
So yeah, you want a well-formulated, like a good skincare brand that knows how to formulate these and deliver them into the skin because that's another thing.
So like, you know,
Every skincare brand has their now GHK formulation because people are demanding it.
But it's been around for 30, 40 years on topical.
The injectable is not FDA approved, of course.
I think it's going to be on the second round of discussions when it comes to the peptides coming back to category one.
The first round is going to have these seven peptides, BPC, TB, et cetera.
And the second round is going to look at GHK.
I don't imagine that makes it.
There's no good human data on that.
But topically, there's great human data on that.
different aesthetic outcomes, especially when coupled with red light therapy, because it seems that the blue pigment and the red light seem to be synergistic in that effect.
There's also some literature when it comes to GHK-CU for post UV damage.
So people that are, you know, sun friendly can use GHK-CU topically to alleviate some of the photo damage.
Of course, dermatologists are going to get mad at us and say, like, you should use sunscreen and don't get damaged in the first place.